- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Tweed Marijuana Reports $1.7 Million Revenue in First Quarter
The Huffington Post reported that Canadian-based medical marijuana company Tweed Marijuana Inc. (TSXV:TWD) reported its first profitable quarter since receiving a federal licence to produce and sell medical cannabis. The company reported a revenue of C$1.7 million in the first quarter of its financial year.
The Huffington Post reported that Canadian-based medical marijuana company Tweed Marijuana Inc. (TSXV:TWD) reported its first profitable quarter since receiving a federal licence to produce and sell medical cannabis. The company reported a revenue of C$1.7 million in the first quarter of its financial year.
As quoted in the market news:
The Ontario-based company, the first marijuana manufacturer in Canada to be publicly traded, earned a net profit of $1 million or two cents per share in the three months ended June 30. A year earlier, it had a net loss of $1.16 million or three cents per share.
Revenue for the first quarter of its financial year was $1.7 million, up 39 per cent from the previous quarter and nine times the less than $189,000 achieved a year ago, when commercial shipments began.
The company, which completed a friendly merger with Bedrocan Cannabis Corp. on Aug. 28, said Monday it sold 215,929 grams at an average price of $7.74 per gram as a stand-alone company during the quarter.
That was up from 166,657 grams at an average of price of $7.25 per gram in the previous quarter and up from 26,205 grams sold in the same quarter last year at an average price of $6.90 per gram.
Outlook Reports
Featured Cannabis Investing News Stocks
Browse Companies
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 2377.49 | +9.84 | |
Silver | 28.22 | +0.01 | |
Copper | 4.46 | +0.10 | |
Oil | 82.51 | -0.18 | |
Heating Oil | 2.54 | -0.04 | |
Natural Gas | 1.75 | +0.03 |
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.